Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 19Phase 1 12Phase 1/2 4Phase 4 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Mastocytosis 1Leukemia, Myelomonocytic, Chronic 1Hypereosinophilic Syndrome 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Sunitinib 4Surgical Procedures, Operative 2Laparoscopy 2Dasatinib 2Biopsy, Fine-Needle 2ripretinib 1motexafin lutetium 1apatinib 1Thoracic Surgery, Video-Assisted 1Surveys and Questionnaires 1Surgical Instruments 1Quality of Life 1Psychiatric Rehabilitation 1Poly(ADP-ribose) Polymerase Inhibitors 1Liver Transplantation 1Indocyanine Green 1Imatinib Mesylate 1Fluorescein 1Endoscopic Mucosal Resection 1Early Intervention, Educational 1Cytological Techniques 1Counseling 1Clobetasol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gastrointestinal Stromal Tumors × Imatinib Mesylate × Clear all
NCT03862768 2019-03-05

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Shanghai Zhongshan Hospital

Phase NA Unknown
92 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡